ASX News
Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| BIC | Ann: Appendix 3X - Gavin Xing Amended | 01/02/16 | 0 | 1.3K | |||
|
|||||||
| BIC | Ann: Appendix 3X - James Everist Amended | 01/02/16 | 0 | 1.8K | |||
|
|||||||
| BIC | Ann: Appendix 3B | 01/02/16 | 0 | 1.1K | |||
|
|||||||
| BIC | Ann: Initial Director's Interest Notice - Gavin Xing | 28/01/16 | 0 | 1.8K | |||
|
|||||||
| BIC | Ann: Initial Director's Interest Notice - James Everist | 28/01/16 | 0 | 1.5K | |||
|
|||||||
| BIC | Ann: Initial Director's Interest Notice - Eric Jiang | 28/01/16 | 0 | 656 | |||
|
|||||||
| BIC | Ann: Final Director's Interest Notice | 28/01/16 | 0 | 439 | |||
|
|||||||
| BIC | Ann: Final Director's Interest Notice - Peter Parthimos | 28/01/16 | 0 | 561 | |||
|
|||||||
See All Discussions
